Immix Biopharma, Inc. IMMX Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s common stock, shares authorized (in shares)?
- Immix Biopharma, Inc. (IMMX) reported common stock, shares authorized (in shares) of $200M in Q1 2026.
- How has Immix Biopharma, Inc.'s common stock, shares authorized (in shares) changed year-over-year?
- Immix Biopharma, Inc.'s common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $200M to $200M.
- What is the long-term trend for Immix Biopharma, Inc.'s common stock, shares authorized (in shares)?
- Over 5 years (2020 to 2025), Immix Biopharma, Inc.'s common stock, shares authorized (in shares) has grown at a 58.5% compound annual growth rate (CAGR), from $20M to $200M.